Tex. Occ. Code Section 562.006
Label


(a)

Unless otherwise directed by the practitioner, the label on the dispensing container must indicate the actual drug or biological product dispensed, indicated by either:

(1)

the brand name; or

(2)

if there is not a brand name, the drug’s generic name or the name of the biological product, the strength of the drug or biological product, and the name of the manufacturer or distributor of the drug or biological product.

(b)

In addition to the information required by Subsection (a), the label on the dispensing container of a drug or biological product dispensed by a Class A or Class E pharmacy must indicate:

(1)

the name, address, and telephone number of the pharmacy;

(2)

the date the prescription is dispensed;

(3)

the name of the prescribing practitioner;

(4)

the name of the patient or, if the drug or biological product was prescribed for an animal, the species of the animal and the name of the owner;

(5)

instructions for use;

(6)

the quantity dispensed;

(7)

if the drug or biological product is dispensed in a container other than the manufacturer’s original container, the date after which the prescription should not be used, determined according to criteria established by board rule based on standards in the United States Pharmacopeia-National Formulary; and

(8)

any other information required by board rule.

(c)

The information required by Subsection (b)(7) may be recorded on any label affixed to the dispensing container.

(d)

Subsection (b) does not apply to a prescription dispensed to a person at the time of release from prison or jail if the prescription is for not more than a 10-day supply of medication.

(e)

If a drug or biological product has been selected other than the one prescribed, the pharmacist shall place on the container the words “Substituted for brand prescribed” or “Substituted for ’brand name’” where “brand name” is the name of the brand name drug or biological product prescribed.

(f)

The board shall adopt rules requiring the label on a dispensing container to be in plain language and printed in an easily readable font size for the consumer.
Acts 1999, 76th Leg., ch. 388, Sec. 1, eff. Sept. 1, 1999.
Amended by:
Acts 2007, 80th Leg., R.S., Ch. 457 (H.B. 948), Sec. 1, eff. September 1, 2007.
Acts 2009, 81st Leg., R.S., Ch. 289 (H.B. 19), Sec. 1, eff. September 1, 2009.
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 6, eff. September 1, 2015.

Source: Section 562.006 — Label, https://statutes.­capitol.­texas.­gov/Docs/OC/htm/OC.­562.­htm#562.­006 (accessed Jun. 5, 2024).

562.001
Definitions
562.002
Legislative Intent
562.003
Disclosure of Price
562.004
Prescription Transmitted Orally by Practitioner
562.005
Record of Dispensed Drug or Biological Product
562.006
Label
562.007
Refills
562.008
Generic Equivalent or Interchangeable Biological Product Authorized
562.009
Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product
562.010
Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product
562.011
Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product
562.012
Substitution of Dosage Form Permitted
562.013
Applicability of Subchapter
562.014
Narrow Therapeutic Index Drugs
562.015
Dispensing Directive
562.016
List of Approved Interchangeable Biological Products
562.0051
Communication Regarding Certain Dispensed Biological Products
562.052
Release of Confidential Records
562.053
Reports to Board
562.054
Emergency Refills
562.055
Report to Texas Department of Health
562.056
Practitioner-patient Relationship Required
562.057
Administration of Epinephrine
562.0061
Other Prescription Information
562.0062
Required Statement Regarding Medication Disposal
562.101
Supervision of Pharmacy
562.102
Confidential Record
562.103
Display of Licenses by Pharmacy
562.104
Toll-free Telephone Number Required
562.105
Maintenance of Records
562.106
Notification
562.107
Written Consumer Information Required
562.108
Emergency Medication Kits
562.109
Automated Pharmacy Systems
562.110
Telepharmacy Systems
562.112
Practitioner-patient Relationship Required
562.0141
Transplant Immunosuppressant Drug Product Selection Prohibited
562.0142
Adoption of Rules
562.151
Definitions
562.152
Compounding for Office Use
562.153
Requirements for Office Use Compounding
562.154
Distribution of Compounded and Prepackaged Products to Certain Pharmacies
562.155
Compounding Service and Compounded Drug Products
562.156
Compounded Sterile Preparation
562.0541
Emergency Refills of Insulin and Insulin-related Equipment or Supplies
562.1011
Operation of Class C Pharmacy in Certain Rural Hospitals
562.1045
Linking Internet Sites
562.1085
Unused Drugs Returned by Certain Pharmacists
562.1086
Limitation on Liability

Accessed:
Jun. 5, 2024

§ 562.006’s source at texas​.gov